News Report | November 11, 2021
Massachusetts Medicaid Program Covers Pear Therapeutics Prescription Digital Therapeutics For Addiction Treatment
On November 9, 2021, the Massachusetts Medicaid program (MassHealth) added two Pear Therapeutics, Inc. prescription digital therapeutics (PDTs) — reSET® and reSET-O® — to the November 2021 MassHealth Drug List Summary Update. Both reSET and reSET-O have been authorized by the U.S. Food and Drug Administration (FDA) for treatment of addiction disorder and opioid use disorder, respectively. Effective November 1, 2021, MassHealth is covering reSET® and reSET-O® for MassHealth members in addiction treatment. The PDTs will be paid for through MassHealth’s Pharmacy Online Processing System (POPS) and do not require prior authorization. MassHealth has about 2 million . . .